Blog
Essays from the desk.
Clinical AI, longevity clinics, neurotech and the Portugal ecosystem — architecture-lens essays with named researchers, not thought-leader mush.
15 / 15
Portugal's Digital Health Strategy: 5-Year Impact Review
Five years in, did Portugal's digital health strategy deliver on patient access? The ledger is more complex than official narratives suggest.
Coimbra's AI Pathology: Diagnosis, Not Prediction
Coimbra isn't predicting cancer with AI. They're diagnosing it. What does that mean for accuracy?
Mind Over Migraine: Porto's Neurotech Focus on Non-Invasive CES
Forget the 'migraine cocktail'. Porto's neurotech sector builds better brains, one non-invasive zap at a time.
Algarve's Longevity Secret: NAD+ IVs & Peptide Protocols
Forget the 'Mediterranean diet' hype. The Algarve's true longevity play involves IV drips and molecular messengers.
Biotech Valley Português: Lisbon Navigates the EU AI Act
EU AI Act lands in Lisbon. Biotech moves from compliance to competitive advantage.
The Algarvian Protocol: Blue Zones, Tech, and Regional Wellness
Forget isolated longevity lessons. The Algarve can architect a regional wellness system, leveraging ancestral wisdom and modern tech.
Portable Neurofeedback for Executive Function: Beyond the Clinic Walls
Clinic-grade neurofeedback is leaving the lab. The architecture of attention demands it.
Algarve's Biometric Data: Patient Rights at Risk?
The Algarve is collecting biometric data at scale. Are we sleepwalking into a privacy disaster?
OpenAI's Healthcare Bet: Dissecting the Clinic vs. Consumer Split
OpenAI's healthcare play isn't a silver bullet. Understand its true impact on clinics, consumers, and your European wellness operation.
Lisbon's AI Gambit: Mount Sinai Reimagines Portuguese Oncology
Forget incremental progress. Lisbon’s Mount Sinai partnership isn’t just tweaking oncology; it’s overhauling the diagnostic architecture.
Faro's BrainPort: Neurofeedback as ADHD & Anxiety Intervention
Faro's BrainPort isn't just treating symptoms; it's re-architecting the brain. A deep dive into neurofeedback's audacious claim.
The top 5 wellness tech innovations to watch in 2027
A curated editorial guide to the wellness tech worth paying attention to in 2027 — continuous biomarkers, closed-loop neuromodulation, longevity clinics, AI care copilots and connected recovery.
Anthropic wants to make drugs. Read the incentive.
When the model vendor becomes the drugmaker, the pipeline is no longer neutral infrastructure — it is a distribution channel with a preferred customer.
Portuguese Longevity Clinics: Decoding the Sesimbra Study
Turns out, 'age reversal' isn't real. Biometric improvements? That's a different story. The Sesimbra Cohort Study delivers.
Portugal Just Became the EU's AI-in-Health Test Bed
Infarmed joined HealthAI's Global Regulatory Network the same week the EU AI Act rules are landing — here's what that actually changes for clinicians, device makers and founders shipping into Europe.